Literature DB >> 19580472

Evidence of extranuclear cell sensitivity to alpha-particle radiation using a microdosimetric model. I. Presentation and validation of a microdosimetric model.

N Chouin1, K Bernardeau, F Davodeau, M Chérel, A Faivre-Chauvet, M Bourgeois, C Apostolidis, A Morgenstern, A Lisbona, M Bardiès.   

Abstract

A microdosimetric model that makes it possible to consider the numerous biological and physical parameters of cellular alpha-particle irradiation by radiolabeled mAbs was developed. It allows for the calculation of single-hit and multi-hit distributions of specific energy within a cell nucleus or a whole cell in any irradiation configuration. Cells are considered either to be isolated or to be packed in a monolayer or a spheroid. The method of calculating energy deposits is analytical and is based on the continuous-slowing-down approximation. A model of cell survival, calculated from the microdosimetric spectra and the microdosimetric radiosensitivity, z(0), was also developed. The algorithm of calculations was validated by comparison with two general Monte Carlo codes: MCNPX and Geant4. Microdosimetric spectra determined by these three codes showed good agreement for numerous geometrical configurations. The analytical method was far more efficient in terms of calculation time: A gain of more than 1000 was observed when using our model compared with Monte Carlo calculations. Good agreements were also observed with previously published results.

Mesh:

Year:  2009        PMID: 19580472     DOI: 10.1667/RR1371.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  10 in total

1.  Redefining relative biological effectiveness in the context of the EQDX formalism: implications for alpha-particle emitter therapy.

Authors:  Robert F Hobbs; Roger W Howell; Hong Song; Sébastien Baechler; George Sgouros
Journal:  Radiat Res       Date:  2014-01       Impact factor: 2.841

2.  A nephron-based model of the kidneys for macro-to-micro α-particle dosimetry.

Authors:  Robert F Hobbs; Hong Song; David L Huso; Margaret H Sundel; George Sgouros
Journal:  Phys Med Biol       Date:  2012-06-15       Impact factor: 3.609

3.  Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis.

Authors:  Markus Essler; Florian C Gärtner; Frauke Neff; Birgit Blechert; Reingard Senekowitsch-Schmidtke; Frank Bruchertseifer; Alfred Morgenstern; Christof Seidl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-01-12       Impact factor: 9.236

4.  A bone marrow toxicity model for ²²³Ra alpha-emitter radiopharmaceutical therapy.

Authors:  Robert F Hobbs; Hong Song; Christopher J Watchman; Wesley E Bolch; Anne-Kirsti Aksnes; Thomas Ramdahl; Glenn D Flux; George Sgouros
Journal:  Phys Med Biol       Date:  2012-05-01       Impact factor: 3.609

5.  Small-scale dosimetry for alpha particle 241Am source cell irradiation and estimation of γ-H2AX foci distribution in prostate cancer cell line PC3.

Authors:  Emma Mellhammar; Magnus Dahlbom; Oskar Vilhelmsson-Timmermand; Sven-Erik Strand
Journal:  EJNMMI Phys       Date:  2022-07-19

Review 6.  Dosimetry for radiopharmaceutical therapy.

Authors:  George Sgouros; Robert F Hobbs
Journal:  Semin Nucl Med       Date:  2014-05       Impact factor: 4.446

Review 7.  Internal microdosimetry of alpha-emitting radionuclides.

Authors:  Werner Hofmann; Wei Bo Li; Werner Friedland; Brian W Miller; Balázs Madas; Manuel Bardiès; Imre Balásházy
Journal:  Radiat Environ Biophys       Date:  2019-12-21       Impact factor: 1.925

Review 8.  Introduction to radiobiology of targeted radionuclide therapy.

Authors:  Jean-Pierre Pouget; Catherine Lozza; Emmanuel Deshayes; Vincent Boudousq; Isabelle Navarro-Teulon
Journal:  Front Med (Lausanne)       Date:  2015-03-17

9.  Microdosimetry for targeted alpha therapy of cancer.

Authors:  Chen-Yu Huang; Susanna Guatelli; Bradley M Oborn; Barry J Allen
Journal:  Comput Math Methods Med       Date:  2012-09-04       Impact factor: 2.238

10.  Comparison between internalizing anti-HER2 mAbs and non-internalizing anti-CEA mAbs in alpha-radioimmunotherapy of small volume peritoneal carcinomatosis using 212Pb.

Authors:  Vincent Boudousq; Laure Bobyk; Muriel Busson; Véronique Garambois; Marta Jarlier; Paraskevi Charalambatou; André Pèlegrin; Salomé Paillas; Nicolas Chouin; François Quenet; Patrick Maquaire; Julien Torgue; Isabelle Navarro-Teulon; Jean-Pierre Pouget
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.